Global Access in Action, a project of the Berkman Klein Center for Internet & Society at Harvard Universityseeks to expand access to lifesaving medicines and combat the communicable disease burden that disproportionately harms the world’s most vulnerable populations. We accomplish this by conducting action-oriented research, supporting breakthrough initiatives, facilitating stakeholder dialogue, and providing policy advice to pharmaceutical firms on best practices to increase impact.  GAIA uses its pragmatic and neutral viewpoint to enable dialogue across traditional boundaries between government, industry, nonprofits, and academia, and to promote new, innovative solutions amongst these parties to create better outcomes.